CNBC

Behind the Merck-Idenix deal

  • Aired: 7/9/2014
    • Length:
    • Plays: ???
Synopsis >

Merck is buying Idenix Pharmaceuticals for $3.85 billion in a deal that has already been approved by the boards of both companies, reports CNBC's Meg Tirrell.

TV GUIDE Users' Most Popular